NIH-funded research R01 grant

Understanding how early life immune cells develop in the spleen

Official title: Early Life B-cell and plasma cell development in the human Spleen: a new paradigm for lifelong immunity

Funded at Emory University · NIH-11133703 · Data updated 2026-11-12

This study is looking at how the immune system develops in young people by examining special cells in the spleen that help fight infections, and it aims to understand how these cells grow and change from childhood to adulthood, which could help us learn more about building strong immunity for life.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startJune 2, 2025
Project endMay 31, 2030
Funding year2025
Award (this year)$778,829
NIH project number1R01AI182276-01A1
Project IDNIH-11133703 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include infants and children under 11 years old, as well as adults interested in understanding their immune system's development.

Less likely to help

Patients with established autoimmune conditions or those who are not in the age range of interest may not benefit from this research.

What this research studies

This research investigates the development of antibody-secreting cells (ASCs) in the spleen during early life, focusing on how these cells differ from those found in adults. The study aims to uncover the mechanisms behind the formation of these immune cells, which are crucial for producing natural antibodies that protect against infections. By using humanized mice, researchers will explore how fetal B-progenitors contribute to the long-term immune response and the persistence of these cells into adulthood. This work could provide insights into how early immune development can influence lifelong immunity.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding of immune system development, potentially enhancing vaccine strategies and treatments for infections in infants and children.

How similar studies have gone: Other research has shown promising results in understanding immune cell development, but this specific focus on early-life splenic ASCs is relatively novel.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Ghosn, Eliver — Emory University
  • Study coordinator: Ghosn, Eliver

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.